This inventor holds 3 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Innovations by Inventor Markus Fischer
Introduction
Markus Fischer is a notable inventor based in Ludwigsburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of modified cytochrome P450 monooxygenases. With a total of 3 patents to his name, Fischer's work has implications for various industrial applications.
Latest Patents
Fischer's latest patents include innovations related to modified cytochrome P450 monooxygenases. The first patent focuses on modified cytochrome P450 monooxygenases with an altered substrate profile. This invention encompasses nucleic acid sequences coding for these enzymes, expression constructs, vectors, and recombinant microorganisms that utilize these vectors. It also details processes for the microbiological production of terminally or subterminally hydroxylated aliphatic carboxylic acids.
The second patent involves novel cytochrome P450 monooxygenases that possess modified substrate specificity. This invention includes nucleotide sequences that code for these enzymes, as well as expression constructs and vectors containing these sequences. Additionally, it describes methods for microbiologically oxidizing various organic substrates, including the production of indigo and indirubin.
Career Highlights
Markus Fischer is currently associated with BASF Aktiengesellschaft, a leading chemical company known for its innovative solutions. His work at BASF has allowed him to explore and develop cutting-edge biotechnological applications.
Collaborations
Fischer has collaborated with esteemed colleagues such as Ulrich Schwaneberg and Rolf Schmid. Their combined expertise has contributed to the advancement of research in the field of cytochrome P450 monooxygenases.
Conclusion
Markus Fischer's contributions to biotechnology through his patents on cytochrome P450 monooxygenases highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the industry and pave the way for future developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile